Mahdi Hatamipour

2.0k total citations · 1 hit paper
37 papers, 1.6k citations indexed

About

Mahdi Hatamipour is a scholar working on Molecular Biology, Immunology and Molecular Medicine. According to data from OpenAlex, Mahdi Hatamipour has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Immunology and 11 papers in Molecular Medicine. Recurrent topics in Mahdi Hatamipour's work include Curcumin's Biomedical Applications (11 papers), Nanoparticle-Based Drug Delivery (10 papers) and Nanoplatforms for cancer theranostics (7 papers). Mahdi Hatamipour is often cited by papers focused on Curcumin's Biomedical Applications (11 papers), Nanoparticle-Based Drug Delivery (10 papers) and Nanoplatforms for cancer theranostics (7 papers). Mahdi Hatamipour collaborates with scholars based in Iran, Australia and United Kingdom. Mahdi Hatamipour's co-authors include Amirhossein Sahebkar, Mahmoud Reza Jaafari, Sedigheh Asgary, Mahtab Keshvari, Awat Feizi, Gholamreza Askari, Sepideh Rahmani, Matteo Pirro, Mahin Ramezani and Seyed Mohammad Gheibi Hayat and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Mahdi Hatamipour

35 papers receiving 1.6k citations

Hit Papers

Treatment of Non-alcoholic Fatty Liver Disease with Curcu... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahdi Hatamipour Iran 18 533 429 330 226 193 37 1.6k
Manouchehr Teymouri Iran 18 440 0.8× 277 0.6× 171 0.5× 80 0.4× 233 1.2× 30 1.1k
Paula B. Luis United States 23 952 1.8× 651 1.5× 251 0.8× 95 0.4× 102 0.5× 40 2.1k
Sosmitha Girisa India 25 1.1k 2.0× 287 0.7× 226 0.7× 158 0.7× 102 0.5× 59 2.2k
Matthias Rath Germany 25 723 1.4× 121 0.3× 292 0.9× 180 0.8× 57 0.3× 150 2.9k
Elham Abdollahi Iran 20 564 1.1× 305 0.7× 349 1.1× 75 0.3× 43 0.2× 43 1.4k
Tathagata Choudhuri India 28 1.2k 2.2× 548 1.3× 173 0.5× 382 1.7× 110 0.6× 52 2.3k
Erika Roat Italy 19 754 1.4× 96 0.2× 193 0.6× 160 0.7× 66 0.3× 26 1.6k
Amir Abbas Momtazi Iran 15 659 1.2× 604 1.4× 181 0.5× 91 0.4× 64 0.3× 17 1.5k
Lu Fan Singapore 23 1.2k 2.3× 121 0.3× 175 0.5× 112 0.5× 148 0.8× 39 2.4k
Chuan Zhang China 26 1.4k 2.6× 90 0.2× 203 0.6× 140 0.6× 109 0.6× 103 2.2k

Countries citing papers authored by Mahdi Hatamipour

Since Specialization
Citations

This map shows the geographic impact of Mahdi Hatamipour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahdi Hatamipour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahdi Hatamipour more than expected).

Fields of papers citing papers by Mahdi Hatamipour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahdi Hatamipour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahdi Hatamipour. The network helps show where Mahdi Hatamipour may publish in the future.

Co-authorship network of co-authors of Mahdi Hatamipour

This figure shows the co-authorship network connecting the top 25 collaborators of Mahdi Hatamipour. A scholar is included among the top collaborators of Mahdi Hatamipour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahdi Hatamipour. Mahdi Hatamipour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hatamipour, Mahdi, et al.. (2025). Identification of potential therapeutic targets for stroke using data mining, network analysis, enrichment, and docking analysis. Computational Biology and Chemistry. 117. 108431–108431.
2.
Zamani, Parvin, Mohammad Mashreghi, Mahere Rezazade Bazaz, et al.. (2023). Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax® against COVID-19 in nonhuman primates. Journal of Controlled Release. 360. 316–334. 17 indexed citations
3.
Nikpoor, Amin Reza, Mahdi Hatamipour, Abolghasem Ajami, et al.. (2023). Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine. Scientific Reports. 13(1). 5802–5802. 9 indexed citations
4.
Momtazi‐Borojeni, Amir Abbas, et al.. (2022). Preclinical toxicity assessment of anionic nanoliposomes. Advanced Industrial and Engineering Polymer Research. 7(1). 144–150. 3 indexed citations
5.
Gheybi, Fatemeh, Seyedeh Hoda Alavizadeh, Seyed Mahdi Rezayat, et al.. (2021). pH-Sensitive PEGylated Liposomal Silybin: Synthesis, In Vitro and In Vivo Anti-Tumor Evaluation. Journal of Pharmaceutical Sciences. 110(12). 3919–3928. 16 indexed citations
6.
Hatamipour, Mahdi, Farzin Hadizadeh, Mahmoud Reza Jaafari, et al.. (2021). Anti-Proliferative Potential of Fluorinated Curcumin Analogues:Experimental and Computational Analysis and Review of the Literature. Current Medicinal Chemistry. 29(8). 1459–1471. 8 indexed citations
7.
Hayat, Seyed Mohammad Gheibi, Mahmoud Reza Jaafari, Mahdi Hatamipour, Peter E. Penson, & Amirhossein Sahebkar. (2020). Liposome Circulation Time is Prolonged by CD47 Coating. Protein and Peptide Letters. 27(10). 1029–1037. 24 indexed citations
8.
Reiner, Željko, Mahdi Hatamipour, Maciej Banach, et al.. (2020). Statins and the COVID-19 main protease: in silico evidence on direct interaction. Archives of Medical Science. 16(3). 490–496. 191 indexed citations
9.
Hayat, Seyed Mohammad Gheibi, Mahmoud Reza Jaafari, Mahdi Hatamipour, Tannaz Jamialahmadi, & Amirhossein Sahebkar. (2020). Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin. Expert Opinion on Drug Delivery. 17(7). 1049–1058. 17 indexed citations
10.
Farhadi, Faegheh, et al.. (2020). A validated 1H-NMR method for quantitative analysis of DOTAP lipid in nanoliposomes containing soluble Leishmania antigen. Journal of Pharmaceutical and Biomedical Analysis. 194. 113809–113809. 4 indexed citations
11.
Gholizadeh, Zahra, Amin Reza Nikpoor, Mahdi Hatamipour, et al.. (2020). Vaccination with dendritic cells pulsed ex vivo with gp100 peptide-decorated liposomes enhances the efficacy of anti PD-1 therapy in a mouse model of melanoma. Vaccine. 38(35). 5665–5677. 17 indexed citations
12.
Hatamipour, Mahdi, Mahmoud Reza Jaafari, Amir Abbas Momtazi‐Borojeni, Mahin Ramezani, & Amirhossein Sahebkar. (2019). Evaluation of the Anti-Tumor Activity of Niclosamide Nanoliposomes Against Colon Carcinoma. Current Molecular Pharmacology. 13(3). 245–250. 6 indexed citations
13.
Hatamipour, Mahdi, Mahmoud Reza Jaafari, Amir Abbas Momtazi‐Borojeni, Mahin Ramezani, & Amirhossein Sahebkar. (2019). Nanoliposomal Encapsulation Enhances In Vivo Anti-Tumor Activity of Niclosamide against Melanoma. Anti-Cancer Agents in Medicinal Chemistry. 19(13). 1618–1626. 14 indexed citations
14.
Nik, Maryam Ebrahimi, Bizhan Malaekeh‐Nikouei, Mohamadreza Amin, et al.. (2019). Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma. Scientific Reports. 9(1). 9527–9527. 53 indexed citations
15.
Hatamipour, Mahdi, et al.. (2019). Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids.. SHILAP Revista de lepidopterología. 22(3). 282–289. 91 indexed citations
16.
Hatamipour, Mahdi, Thomas P. Johnston, & Amirhossein Sahebkar. (2018). One Molecule, Many Targets and Numerous Effects: The Pleiotropy of Curcumin Lies in its Chemical Structure. Current Pharmaceutical Design. 24(19). 2129–2136. 35 indexed citations
17.
Hatamipour, Mahdi, et al.. (2018). Demethoxycurcumin: A naturally occurring curcumin analogue with antitumor properties. Journal of Cellular Physiology. 233(12). 9247–9260. 37 indexed citations
18.
Razazan, Atefeh, Javad Behravan, Atefeh Arab, et al.. (2017). Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model. PLoS ONE. 12(10). e0185099–e0185099. 46 indexed citations
19.
Ramezani, Mahin, Mahdi Hatamipour, & Amirhosein Sahebkar. (2017). Promising anti‐tumor properties of bisdemethoxycurcumin: A naturally occurring curcumin analogue. Journal of Cellular Physiology. 233(2). 880–887. 65 indexed citations
20.
Tayarani‐Najaran, Zahra, Seyed Hadi Mousavi, Javad Asili, et al.. (2013). Cytotoxic and apoptogenic properties of three isolated diterpenoids from Salvia chorassanica through bioassay-guided fractionation. Food and Chemical Toxicology. 57. 346–351. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026